| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Pediatrics, School of Medicine, and
Institute of Organ Transplants, Reconstructive Medicine and Tissue Engineering, Graduate School of Medicine, Shinshu University, and
Blood Transfusion Service, Shinshu University Hospital, Matsumoto, Japan; and
Research and Development, Mitsubishi Kagaku Bio-Clinical Laboratories, Tokyo, Japan
We examined the effects of IL-9 on human mast cell development from CD34+ cord blood (CB) and peripheral blood cells in serum-deprived cultures. IL-9 apparently enhanced cell production under stimulation with stem cell factor (SCF) from CD34+ CB cells. A great majority of the cultured cells grown with SCF + IL-9 became positive for tryptase at 4 wk. In methylcellulose cultures of CD34+ CB cells, IL-9 increased both the number and size of mast cell colonies grown with SCF. Furthermore, SCF + IL-9 caused an exclusive expansion of mast cell colony-forming cells in a 2-wk liquid culture of CD34+ CB cells, at a level markedly greater than for SCF alone. Clonal cell cultures and RT-PCR analysis showed that the targets of SCF + IL-9 were the CD34+CD38+ CB cells rather than the CD34+CD38- CB cells. IL-9 neither augmented the SCF-dependent generation of progeny nor supported the survival of 6-wk-cultured mast cells. Moreover, there was no difference in the appearance of tryptase+ cells and histamine content in the cultured cells between SCF and SCF + IL-9. The addition of IL-9 increased numbers of mast cell colonies grown with SCF from CD34+ peripheral blood cells in children with or without asthma. It is of interest that mast cell progenitors of asthmatic patients responded to SCF + IL-9 to a greater extent than those of normal controls. Taken together, IL-9 appears to act as a potent enhancer for the SCF-dependent growth of mast cell progenitors in humans, particularly asthmatic patients.
This article has been cited by other articles:
|
|
 |
|
  E. E. Forbes, K. Groschwitz, J. P. Abonia, E. B. Brandt, E. Cohen, C. Blanchard, R. Ahrens, L. Seidu, A. McKenzie, R. Strait, et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity J. Exp. Med., April 14, 2008; 205(4): 897 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Jiang, Y. Kanaoka, C. Feng, K. Nocka, S. Rao, and J. A. Boyce Cutting edge: interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling. J. Immunol., September 1, 2006; 177(5): 2755 - 2759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kulka, N. Fukuishi, M. Rottem, Y. A. Mekori, and D. D. Metcalfe Mast cells, which interact with Escherichia coli, up-regulate genes associated with innate immunity and become less responsive to Fc{epsilon}RI-mediated activation J. Leukoc. Biol., February 1, 2006; 79(2): 339 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nagato, H. Kobayashi, K. Kishibe, M. Takahara, T. Ogino, H. Ishii, K. Oikawa, N. Aoki, K. Sato, S. Kimura, et al. Expression of Interleukin-9 in Nasal Natural Killer/T-Cell Lymphoma Cell Lines and Patients Clin. Cancer Res., December 1, 2005; 11(23): 8250 - 8257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bagga, K. S. Price, D. A. Lin, D. S. Friend, K. F. Austen, and J. A. Boyce Lysophosphatidic acid accelerates the development of human mast cells Blood, December 15, 2004; 104(13): 4080 - 4087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yang, K. Aozasa, K. Oshimi, and K. Takada Epstein-Barr Virus (EBV)-Encoded RNA Promotes Growth of EBV-Infected T Cells through Interleukin-9 Induction Cancer Res., August 1, 2004; 64(15): 5332 - 5337. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
